Simon M - Search Results

1

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.

Weller M, Felsberg J, Hartmann C, Berger H, Steinbach JP, Schramm J, Westphal M, Schackert G, Simon M, Tonn JC, Heese O, Krex D, Nikkhah G, Pietsch T, Wiestler O, Reifenberger G, von Deimling A, Loeffler M. Weller M, et al. Among authors: simon m. J Clin Oncol. 2009 Dec 1;27(34):5743-50. doi: 10.1200/JCO.2009.23.0805. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805672 Free article.

2

Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas.

Simon M, Köster G, Menon AG, Schramm J. Simon M, et al. Acta Neuropathol. 1999 Nov;98(5):444-52. doi: 10.1007/s004010051107. Acta Neuropathol. 1999. PMID: 10541865

3

Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.

Simon M, Köster G, Ludwig M, Mahlberg R, Rho S, Watzka M, Schramm J. Simon M, et al. Acta Neuropathol. 2001 Aug;102(2):167-74. doi: 10.1007/s004010100374. Acta Neuropathol. 2001. PMID: 11563632

4

Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas.

Joachim T, Ram Z, Rappaport ZH, Simon M, Schramm J, Wiestler OD, von Deimling A. Joachim T, et al. Among authors: simon m. Int J Cancer. 2001 Oct 15;94(2):218-21. doi: 10.1002/ijc.1467. Int J Cancer. 2001. PMID: 11668501 Free article.

5

Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.

Simon M, Park TW, Köster G, Mahlberg R, Hackenbroch M, Boström J, Löning T, Schramm J. Simon M, et al. J Neurooncol. 2001 Dec;55(3):149-58. doi: 10.1023/a:1013863630293. J Neurooncol. 2001. PMID: 11859969

6

Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III.

Kristof RA, Neuloh G, Hans V, Deckert M, Urbach H, Schlegel U, Simon M, Schramm J. Kristof RA, et al. Among authors: simon m. J Neurooncol. 2002 Sep;59(3):231-7. doi: 10.1023/a:1019987116596. J Neurooncol. 2002. PMID: 12241120

7

Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression.

Simon M, Simon C, Köster G, Hans VH, Schramm J. Simon M, et al. Among authors: simon c. J Neurooncol. 2002 Oct;60(1):1-12. doi: 10.1023/a:1020226130478. J Neurooncol. 2002. PMID: 12416540

8

Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.

Hartmann C, Nümann A, Mueller W, Holtkamp N, Simon M, von Deimling A. Hartmann C, et al. Among authors: simon m. Int J Cancer. 2004 Mar 1;108(6):839-44. doi: 10.1002/ijc.11638. Int J Cancer. 2004. PMID: 14712485 Free article.

9

NF2 mutations in secretory and other rare variants of meningiomas.

Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A. Hartmann C, et al. Among authors: simon m. Brain Pathol. 2006 Jan;16(1):15-9. doi: 10.1111/j.1750-3639.2006.tb00557.x. Brain Pathol. 2006. PMID: 16612978 Free PMC article.

10

Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme.

Simon M, Ludwig M, Fimmers R, Mahlberg R, Müller-Erkwoh A, Köster G, Schramm J. Simon M, et al. Neurosurgery. 2006 Nov;59(5):1078-85; discussion 1085. doi: 10.1227/01.NEU.0000245590.08463.5B. Neurosurgery. 2006. PMID: 17016233 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,335 results

Search Page